• Asbestos
• Avandia
• Cypher Stent
• Digitek
• ETHEX
• Food Contamination
• Fosamax
• Gadolinium
• Guidant
• Heparin
• Levaquin
• Medtronic
• Prempro
• Raptiva
• Taxus Stent
• Yamaha Rhino
• Yaz, Yasmin & Ocella

We have represented thousands of people, including some of the largest and most important injury cases ever brought in the United States.

In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney General as the only Arizona law firm to represent the State against American tobacco companies. As a result, Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related illnesses, maintain educational programs to prevent young people from smoking, and fund other important State programs.

Study Cites Increased Death Risk From Serevent
Washington Post
June 6, 2006

FDA Sets Strong Warnings for Asthma Drug Labels
Reuters
May 15, 2006

Death Risk for Serevent
Fox News
March 8, 2006

More Serevent News Articles

August 15, 2005 —O'Steen & Harrison filed suit against GlaxoSmithKline on behalf of a family whose loved one died after suffering a serious asthma attack. Shortly after using his Serevent inhaler, our client doubled over, unable to catch his breath.

The lawsuit contends Serevent is defective as designed and is unreasonably dangerous. Serevent wasn't subject to a black box warning as a result of adverse reactions like these until August 2003, nearly four years after the death of our client.

March 8, 2006—The FDA announced Serevent will include a Black Box Warning informing patients that the drug may increase the risk of asthma-related death.

Serevent has included a Black Box Warning since August 2003 when a clinical trial assessing the safety of Serevent found that Serevent users were more likely to suffer life-threatening asthma attacks. The results of the study are alarming—36 people either had life-threatening attacks or died while on Serevent. The risk of death was threefold among those taking Serevent compared to a placebo.

The FDA said that while Serevent decreases how often asthma attacks occur, the inhaler may make the attacks that do occur more severe.

In May 2006, the FDA said that Serevent and two other asthma drugs associated with life-threatening attacks should only be used after other medicines fail to control asthma.

Dr. David Graham of the FDA testified before Congress in November 2004 that he was concerned about the safety of Serevent. He believed the warnings in effect at the time were insufficient and suggested more stringent action be taken to protect asthma sufferers.

Following Dr. Graham's testimony, the FDA created a panel to review the safety of Serevent and two other asthma drugs. The panel recommended that the drugs continue to be sold in spite of evidence of the serious risk to users.

The FDA did, however, strengthen the warning by alerting patients that Serevent may increase the risk of death. The FDA has come under fire in the last several years for its failure to protect the public from Vioxx, a popular arthritis drug found to greatly increase the risk of heart attacks and strokes.

If you or a loved one has suffered a life-threatening asthma attack while taking Serevent, you may be entitled to compensation.

You should act immediately to contact an attorney experienced in matters involving potentially dangerous pharmaceuticals.

O'Steen & Harrison, PLC presently is involved in litigation against GlaxoSmithKline, the manufacturer of Serevent. We invite you to contact us for a free, confidential consultation about your legal rights.

We will represent patients throughout the United States. We can help you, too, wherever you live.

For free answers to your questions about the Serevent lawsuit and serious side effects, please call us toll-free at 1-800-883-8888 or complete this online contact form.